Misplaced Pages

Cypher stent

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
(Redirected from Cypher Stent) Type of drug-eluting stent
The topic of this article may not meet Misplaced Pages's notability guidelines for products and services. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted.
Find sources: "Cypher stent" – news · newspapers · books · scholar · JSTOR (March 2024) (Learn how and when to remove this message)

Cypher is a brand of drug-eluting coronary stent from Cordis Corporation, a Cardinal Health company. During a balloon angioplasty, the stent is inserted into the artery to provide a "scaffold" to open the artery. An anti-rejection-type medication, sirolimus, helps to limit the overgrowth of normal cells while the artery heals which reduces the chance of re-blockage in the treated area known as restenosis, and reduces the chances that another procedure is required.

The Cypher stent was approved for use by the FDA in 2003. Following claims of inconsistent manufacturing processes and poor sales, Johnson & Johnson have announced that it will stop selling Cypher stents by the end of 2011.

See also

References

  1. "Learn about CYPHER Stent, the latest advance in stent technology". Cordis Corporation. Archived from the original on 2004-06-26. Retrieved 2008-04-01.
  2. ^ "CYPHER™ Sirolimus-eluting Coronary Stent - P020026". FDA.gov. U.S. Food and Drug Administration. Retrieved 1 Aug 2016.
  3. "J&J to quit struggling heart stent business". Reuters. 2011-06-15. Retrieved 2011-07-18.


Stub icon

This article related to medical equipment is a stub. You can help Misplaced Pages by expanding it.

Categories: